Chemoinformaics analysis of (-)-10-Epi-alpha-cyperone
| Molecular Weight | 218.34 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 218.167 | nRing | 2 |
| Solubility: LogS | -4.405 | nHRing | 0 |
| Solubility: LogP | 3.565 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.607 |
| Synth | 3.919 |
| Natural Product Likeliness | 2.889 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.749 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.754 |
| MDCK | 0.0000183 |
| BBB | 0.08 |
| PPB | 0.896793 |
| VDSS | 1.673 |
| FU | 0.11556 |
| CYP1A2-inh | 0.28 |
| CYP1A2-sub | 0.691 |
| CYP2c19-inh | 0.404 |
| CYP2c19-sub | 0.878 |
| CYP2c9-inh | 0.154 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.206 |
| CYP2d6-sub | 0.819 |
| CYP3a4-inh | 0.152 |
| CYP3a4-sub | 0.321 |
| CL | 4.347 |
| T12 | 0.398 |
| hERG | 0.022 |
| Ames | 0.019 |
| ROA | 0.053 |
| SkinSen | 0.241 |
| Carcinogencity | 0.451 |
| EI | 0.841 |
| Respiratory | 0.948 |
| NR-Aromatase | 0.805 |
| Antiviral | Yes |
| Prediction | 0.870764 |